SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (408)9/10/2001 2:00:19 PM
From: tuck  Read Replies (1) | Respond to of 1005
 
Hola, HellMongers,

Back from trip with a muscle pull. Story if anyone wants it. I see the market isn't doing much better. But perhaps BLUE HP will have a fresh target in a while . . .

SEATTLE, Sept. 10 /PRNewswire/ -- ZymoGenetics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. All the offered shares will be sold by ZymoGenetics. The joint book-running managers for the offering will be Lehman Brothers Inc. and Merrill Lynch & Co. Bear, Stearns & Co. Inc. and Pacific Growth Equities, Inc. will be co- managers. ZymoGenetics is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic protein-based products for the treatment of human disease.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.<<

snip

GNVC looking mighty cheap again. Should it go to $1.87, BLUE HP will buy 100 shares. Though there's always MCLS . . .

Cheers, Tuck